News in the Life Sciences Industry

NEW YORK, Sept. 26, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of STAAR Surgical Company (NASDAQ: STAA) between February 26, 2020 and August 10, 2020, inclusive (the "Class Period") of the important October 19, 2020 lead plaintiff... Read more ››

NEW YORK, Sept. 25, 2020 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against BioMarin Pharmaceuticals, Inc. ("BioMarin" or the "Company") (NASDAQ: BMRN) and certain of its officers. The class action, filed in United States District Court for the Northern... Read more ››

NEW YORK, Sept. 25, 2020 /PRNewswire/ --

SILVER SPRING, Md., Sept. 25, 2020 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Nucala (mepolizumab) for adults and children aged 12 years and older with hypereosinophilic syndrome (HES) for six months or longer without another identifiable non-blood related cause of... Read more ››

SAN DIEGO, Sept. 25, 2020 /PRNewswire/ -- Genelux Corporation, a privately-held clinical-stage immunotherapy company, today announced that it has entered into a convertible note and warrant financing transaction with Woodward Diversified Capital (WDC). Genelux and WDC have completed the first... Read more ››

WASHINGTON, Sept. 25, 2020 /PRNewswire/ -- The American Pharmacists Association (APhA) issued the following statement today after the Food and Drug Administration (FDA) finalized the rule for the legal importation of drugs from Canada:

DUBLIN, Sept. 25, 2020 /PRNewswire/ -- The Read more ››

DUBLIN, Sept. 25, 2020 /PRNewswire/ -- The Read more ››

LOS ANGELES, Sept. 25, 2020 /PRNewswire/ -- Riding off of their continuous success in dental 3D printing, SprintRay announced three innovative products in the dental 3D printing space:

DUBLIN, Sept. 25, 2020 /PRNewswire/ -- The Read more ››

DUBLIN, Sept. 25, 2020 /PRNewswire/ -- The Read more ››

SAN ANTONIO, Sept. 25, 2020 /PRNewswire/ -- COVID-19 testing startup Read more ››

SOUTH PLAINFIELD, N.J., Sept. 25, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on September 21, 2020 it approved non-statutory stock options to purchase an aggregate of 75,670 shares of its common stock and 12,845 restricted stock units ("RSUs"), each representing... Read more ››